Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women,10.1002/jbmr.191,Journal of Bone and Mineral Research,Steven

• ...This study was conducted before the completion of the GENERATIONS trial, a phase III placebo-controlled study of 9,354 postmenopausal women with low bone mass or osteoporosis designed to assess the effect of arzoxifene on clinical endpoints, including fractures [9]...

D. L. Kendler, et al. Arzoxifene versus raloxifene: effect on bone and safety parameters in ...